Amedisys Historical Financial Ratios
| AMED Stock | USD 91.15 4.86 5.06% |
Amedisys is presently reporting on over 112 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 3.0E-4, PTB Ratio of 2.57 or Days Sales Outstanding of 51.19 will help investors to properly organize and evaluate Amedisys financial condition quickly.
Amedisys |
About Amedisys Financial Ratios Analysis
AmedisysFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Amedisys investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Amedisys financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Amedisys history.
Amedisys Financial Ratios Chart
Amedisys financial ratios usually calculated using numerical values taken directly from Amedisys financial statements such as income statements or balance sheets. They help investors to obtain meaningful information about Amedisys. Most financial ratios help to conduct quantitative analysis to assess vital information about the company's valuation as well as profitability and liquidity indicators such as leverage, growth, profit margins, and different types of rates of return.
At present, Amedisys' Free Cash Flow Yield is projected to slightly decrease based on the last few years of reporting. The current year's Invested Capital is expected to grow to 0.40, whereas PTB Ratio is forecasted to decline to 2.57. Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Amedisys stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Amedisys sales, a figure that is much harder to manipulate than other Amedisys multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company’s stock price to its revenues, calculated by dividing the company’s market cap by its total sales or revenue over a 12-month period.Dividend Yield
Dividend Yield is Amedisys dividend as a percentage of Amedisys stock price. Amedisys dividend yield is a measure of Amedisys stock productivity, which can be interpreted as interest rate earned on an Amedisys investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Ptb Ratio
Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.Most ratios from Amedisys' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Amedisys current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amedisys. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. For information on how to trade Amedisys Stock refer to our How to Trade Amedisys Stock guide.At present, Amedisys' Free Cash Flow Yield is projected to slightly decrease based on the last few years of reporting. The current year's Invested Capital is expected to grow to 0.40, whereas PTB Ratio is forecasted to decline to 2.57.
| 2023 | 2024 (projected) | Dividend Yield | 2.91E-4 | 2.59E-4 | Price To Sales Ratio | 1.39 | 0.86 |
Amedisys fundamentals Correlations
Click cells to compare fundamentals
Amedisys Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Amedisys fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Price To Sales Ratio | 2.74 | 4.61 | 2.39 | 1.22 | 1.39 | 0.86 | |
| Ptb Ratio | 8.38 | 11.8 | 5.67 | 2.58 | 2.91 | 2.57 | |
| Days Sales Outstanding | 44.34 | 44.96 | 45.33 | 48.73 | 53.56 | 51.19 | |
| Book Value Per Share | 19.93 | 24.85 | 28.53 | 32.34 | 32.72 | 34.35 | |
| Free Cash Flow Yield | 0.0362 | 0.0297 | 0.0345 | 0.0464 | 0.0402 | 0.0422 | |
| Invested Capital | 0.17 | 0.0153 | 0.51 | 0.38 | 0.59 | 0.4 | |
| Operating Cash Flow Per Share | 6.28 | 8.87 | 5.79 | 4.1 | 4.21 | 2.35 | |
| Capex To Depreciation | (0.15) | (0.0785) | (0.0943) | (0.1) | (0.53) | (0.56) | |
| Pb Ratio | 8.38 | 11.8 | 5.67 | 2.58 | 2.91 | 2.57 | |
| Ev To Sales | 2.89 | 4.72 | 2.61 | 1.45 | 1.54 | 0.94 | |
| Free Cash Flow Per Share | 6.04 | 8.71 | 5.58 | 3.88 | 3.82 | 4.01 | |
| Roic | 0.24 | 0.14 | 0.17 | 0.0835 | (0.0361) | (0.0379) | |
| Inventory Turnover | 15.45 | 100.75 | 91.83 | 49.98 | 44.98 | 54.42 | |
| Net Income Per Share | 3.95 | 5.64 | 6.4 | 3.65 | (0.3) | (0.28) | |
| Days Of Inventory On Hand | 2.78 | 23.62 | 3.62 | 7.3 | 6.57 | 6.3 | |
| Payables Turnover | 36.8 | 27.78 | 32.27 | 28.82 | 63.01 | 66.16 | |
| Capex To Revenue | (0.004033) | (0.002574) | (0.003036) | (0.003245) | (0.005685) | (0.005969) | |
| Cash Per Share | 0.94 | 2.51 | 1.31 | 1.25 | 4.47 | 4.7 | |
| Pocfratio | 26.56 | 33.05 | 27.97 | 20.38 | 22.59 | 23.72 | |
| Interest Coverage | 12.23 | 19.86 | 26.45 | 8.13 | 6.17 | 6.48 | |
| Capex To Operating Cash Flow | (0.039) | (0.0185) | (0.0356) | (0.0541) | (0.0927) | (0.0973) | |
| Pfcf Ratio | 27.64 | 33.67 | 29.01 | 21.55 | 24.9 | 26.14 | |
| Days Payables Outstanding | 10.49 | 9.92 | 13.14 | 11.31 | 5.79 | 5.5 | |
| Income Quality | 1.58 | 1.56 | 0.9 | 1.13 | (14.07) | (13.37) | |
| Roe | 0.2 | 0.23 | 0.22 | 0.11 | (0.009139) | (0.008682) | |
| Ev To Operating Cash Flow | 28.02 | 33.83 | 30.64 | 24.11 | 25.08 | 26.33 | |
| Pe Ratio | 42.3 | 52.02 | 25.27 | 22.9 | (317.93) | (302.03) | |
| Return On Tangible Assets | 0.24 | 0.33 | 0.38 | 0.2 | (0.0137) | (0.013) | |
| Ev To Free Cash Flow | 29.16 | 34.47 | 31.77 | 25.49 | 27.64 | 29.02 | |
| Earnings Yield | 0.0236 | 0.0192 | 0.0396 | 0.0437 | (0.003145) | (0.003303) | |
| Intangibles To Total Assets | 0.52 | 0.57 | 0.64 | 0.7 | 0.65 | 0.38 | |
| Net Debt To E B I T D A | 1.23 | 0.77 | 1.52 | 1.94 | 1.57 | 1.3 | |
| Current Ratio | 1.01 | 1.07 | 0.79 | 0.95 | 1.09 | 1.22 | |
| Tangible Book Value Per Share | (2.54) | (6.02) | (10.14) | (8.67) | (6.98) | (6.63) | |
| Receivables Turnover | 8.23 | 8.12 | 8.05 | 7.49 | 6.81 | 6.61 | |
| Graham Number | 42.06 | 56.16 | 64.12 | 51.52 | 14.84 | 19.54 | |
| Shareholders Equity Per Share | 19.93 | 24.85 | 28.53 | 32.34 | 32.72 | 34.35 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Amedisys is a strong investment it is important to analyze Amedisys' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Amedisys' future performance. For an informed investment choice regarding Amedisys Stock, refer to the following important reports:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Amedisys. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. For information on how to trade Amedisys Stock refer to our How to Trade Amedisys Stock guide.Note that the Amedisys information on this page should be used as a complementary analysis to other Amedisys' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Amedisys Stock analysis
When running Amedisys' price analysis, check to measure Amedisys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amedisys is operating at the current time. Most of Amedisys' value examination focuses on studying past and present price action to predict the probability of Amedisys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amedisys' price. Additionally, you may evaluate how the addition of Amedisys to your portfolios can decrease your overall portfolio volatility.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |
Is Amedisys' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amedisys. If investors know Amedisys will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amedisys listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.43) | Earnings Share (0.64) | Revenue Per Share 69.004 | Quarterly Revenue Growth 0.027 | Return On Assets 0.0626 |
The market value of Amedisys is measured differently than its book value, which is the value of Amedisys that is recorded on the company's balance sheet. Investors also form their own opinion of Amedisys' value that differs from its market value or its book value, called intrinsic value, which is Amedisys' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amedisys' market value can be influenced by many factors that don't directly affect Amedisys' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amedisys' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amedisys is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amedisys' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.